| Dr Alyssa Jelinek, | |
|
725 American Ave, Waukesha, WI 53188-5031 | |
| (262) 928-1000 | |
| Not Available |
| Full Name | Dr Alyssa Jelinek |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Neonatal |
| Location | 725 American Ave, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033779509 | NPI | - | NPPES |
| Entity Name | St Francis Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447605514 PECOS PAC ID: 7214821909 Enrollment ID: O20040212000408 |
News Archive
Researchers from the University of Illinois at Urbana-Champaign and the University of California-Davis are combining in vivo experimentation with computation for highly accurate prediction of the genome-wide binding pattern of a key protein involved in brain disorders.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
Control and prevention of Aedes-transmitted viruses, such as dengue, chikungunya, or Zika relies heavily on vector control approaches. Given the effort and cost involved in implementation of vector control, targeting of control measures is highly desirable. However, it is unclear to what extent the effectiveness of highly focal and reactive control measures depends on the commuting and movement patterns of humans.
Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient's future risk of death, according to published studies. Now, results of a new study show a similar effect among those who continued these habits after cancer diagnosis.
› Verified 8 days ago
| Entity Name | Children's Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932208808 PECOS PAC ID: 2668370966 Enrollment ID: O20040406000939 |
News Archive
Researchers from the University of Illinois at Urbana-Champaign and the University of California-Davis are combining in vivo experimentation with computation for highly accurate prediction of the genome-wide binding pattern of a key protein involved in brain disorders.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
Control and prevention of Aedes-transmitted viruses, such as dengue, chikungunya, or Zika relies heavily on vector control approaches. Given the effort and cost involved in implementation of vector control, targeting of control measures is highly desirable. However, it is unclear to what extent the effectiveness of highly focal and reactive control measures depends on the commuting and movement patterns of humans.
Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient's future risk of death, according to published studies. Now, results of a new study show a similar effect among those who continued these habits after cancer diagnosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alyssa Jelinek, 725 American Ave, Waukesha, WI 53188-5031 Ph: () - | Dr Alyssa Jelinek, 725 American Ave, Waukesha, WI 53188-5031 Ph: (262) 928-1000 |
News Archive
Researchers from the University of Illinois at Urbana-Champaign and the University of California-Davis are combining in vivo experimentation with computation for highly accurate prediction of the genome-wide binding pattern of a key protein involved in brain disorders.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
Control and prevention of Aedes-transmitted viruses, such as dengue, chikungunya, or Zika relies heavily on vector control approaches. Given the effort and cost involved in implementation of vector control, targeting of control measures is highly desirable. However, it is unclear to what extent the effectiveness of highly focal and reactive control measures depends on the commuting and movement patterns of humans.
Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient's future risk of death, according to published studies. Now, results of a new study show a similar effect among those who continued these habits after cancer diagnosis.
› Verified 8 days ago
Mr. Carla L Foley, MSN FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20611 Watertown Rd, Waukesha, WI 53186 Phone: 262-798-1910 | |
Annette Quinn, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Prohealth Care Women's Center, Waukesha, WI 53188 Phone: 262-928-3500 | |
Renelle L Staus, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W231n1440 Corporate Ct, Waukesha, WI 53186 Phone: 262-896-6000 | |
Ms. Danielle Marie Bernacchi, MSN, FNP-C, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W308s2809 Wild Berry Ct, Waukesha, WI 53188 Phone: 262-391-0575 | |
Miss Amelia Tollefson, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1130 W Sunset Dr, Waukesha, WI 53189 Phone: 866-389-2727 | |
Katie L Scott, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave Ste 310, Waukesha, WI 53188 Phone: 262-928-5900 | |
Kaitlyn Solveson, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2428 N Grandview Blvd Ste 102, Waukesha, WI 53188 Phone: 877-307-3226 Fax: 866-384-9486 |